Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarction.
Sissel J GodtfredsenKristian H KragholmAnna Meta Dyrvig KristensenTarek BekfaniRikke SørensenMaurizio SessaChristian Torp-PedersenDeepak L BhattManan PareekPublished in: European heart journal open (2023)
In patients with AF on OAC who underwent PCI for MI, treatment with ticagrelor or prasugrel vs. clopidogrel was associated with reduced ischaemic risk, without a concomitantly increased bleeding risk.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- acute myocardial infarction
- atrial fibrillation
- coronary artery disease
- coronary artery bypass grafting
- coronary artery bypass
- heart failure
- left ventricular